Moody Aldrich Partners’s Natus Medical Inc NTUS Stock Holding History

Moody Aldrich Partners’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-68,217	Closed	-$2.35M	–	118
2018 Q2	$2.35M	Buy	68,217 +29,190	+75%	+$1.02M	0.84%	60
2018 Q1	$1.31M	Buy	39,027 +5,542	+17%	+$175K	0.84%	65
2017 Q4	$1.28M	Sell	33,485 -720	-2%	-$28.7K	1.04%	48
2017 Q3	$1.28M	Buy	34,205 +4,050	+13%	+$143K	1.32%	29
2017 Q2	$1.13M	Buy	30,155 +11,840	+65%	+$428K	1.4%	22
2017 Q1	$719K	Sell	18,315 -30,210	-62%	-$1.13M	1.23%	28
2016 Q4	$1.69M	Buy	48,525 +10,290	+27%	+$404K	1.09%	42
2016 Q3	$1.5M	Buy	38,235 +3,475	+10%	+$139K	1.05%	39
2016 Q2	$1.31M	Buy	34,760 +19,375	+126%	+$649K	1.09%	39
2016 Q1	$591K	Buy	+15,385	New	+$573K	1.24%	30

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Moody Aldrich Partners's NTUS Position: Q3 2018 in Review

Moody Aldrich Partners sold out of Natus Medical Inc (NTUS) in Q3 2018, closing a stake of 68,217 shares — an estimated $2.35M sold.

Moody Aldrich Partners first reported a position in NTUS in Q1 2016 and held it in 10 quarters. The position peaked at $2.35M in Q2 2018. 176 funds tracked by Wall St. Rank hold NTUS as of Q3 2018.

Moody Aldrich Partners reported no remaining Natus Medical Inc position as of Q3 2018 after selling out during the quarter.
Moody Aldrich Partners sold 68,217 Natus Medical Inc shares in Q3 2018, an estimated $2.35M.
Moody Aldrich Partners first reported a position in Natus Medical Inc in Q1 2016 and held it in 10 quarters.
Moody Aldrich Partners's Natus Medical Inc position peaked at $2.35M in Q2 2018.
176 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2018.

Based on Moody Aldrich Partners's 13F filing for Q3 2018, filed 31 Oct 2018.